Cardiovascular therapy compositions
A composition for use in cardiovascular therapy includes transfer factor. The transfer factor may be nonmammalian transfer factor, such as that derived from eggs, or mammalian transfer factor, such as that derived from colostrum. The composition may also include one or more of the following: an LDL receptor-binding element; a blood flow-enhancing element; a cholesterol reducing element; a fat oxidation prevention element, and an antioxidant. Treatment methods include enlisting the immune system of a subject receiving therapy to attack pathogens that cause inflammation of blood vessels or to otherwise reduce inflammation of blood vessels.
1. A nutritional supplement, comprising:
at least one vitamin;
at least one mineral;
at least one herb or plant extract selected from the group comprising Butcher's Broom, Ginkgo biloba, hawthorn, garlic, red rice yeast extract, resveratrol and ginger; and
a cardiovascular support component, consisting of:
an inflamation-reducing component for decreasing an amount of inflammation in blood vessels of a subject, comprising transfer factor;
at least one low density lipoprotein (LDL) receptor-binding component;
at least one blood cholesterol reduction component;
at least one blood flow-enhancing component; and
at least one antioxidant.
2. The nutritional supplement of claim 1 , wherein the transfer factor is at least one of an extract from a mammalian source and an extract from a nonmammalian source.
3. The nutritional supplement of claim 1 , wherein the at least one low density lipoprotein (LDL) receptor-binding component is lysine or a lysine salt.
4. The nutritional supplement of claim 1 , wherein the at least one blood flow-enhancing component is at least one of an arginine-containing compound and niacinamide.
5. The nutritional supplement of claim 1 , wherein the at least one antioxidant is a hydrophobic antioxidant.
6. The nutritional supplement of claim 5 , wherein the hydrophobic antioxidant is at least one of beta-carotene, vitamin A, and vitamin E.
7. The nutritional supplement of claim 1 , wherein the at least one antioxidant is Coenzyme Q 10 .
8. The nutritional supplement of claim 1 , wherein the at least one herb or plant extract is a fat oxidation prevention element.
9. A nutritional supplement, comprising:
at least one vitamin;
at least one antioxidant;
at least one mineral;
at least one herb or plant extract selected from the group comprising Butcher's Broom, Ginkgo biloba, hawthorn, garlic, red rice yeast extract, resveratrol and ginger; and
a cardiovascular support component, consisting of:
a pathogen-reducing component for decreasing a number of pathogens in blood vessels of a subject, comprising transfer factor; and
at least one blood flow-enhancing component.
10. The nutritional supplement of claim 9 , wherein the transfer factor is at least one of an extract from a mammalian source and an extract from a nonmammalian source.
11. The nutritional supplement of claim 9 , wherein the at least one mineral is part of an LDL receptor-binding component.
12. The nutritional supplement of claim 11 , wherein the LDL receptor-binding component is a lysine salt of the at least one mineral.
13. The nutritional supplement of claim 9 , wherein the at least one blood flow-enhancing component is at least one of an arginine-containing compound and niacinamide.
14. The nutritional supplement of claim 9 , wherein at least one vitamin, at least one mineral, or at least one herb is the at least one antioxidant.
15. The nutritional supplement of claim 14 , wherein the at least one antioxidant is a hydrophobic antioxidant.
16. The nutritional supplement of claim 15 , wherein the at least one antioxidant is at least one of beta-carotene, vitamin A, and vitamin E.
17. The nutritional supplement of claim 9 , wherein the at least one antioxidant is Coenzyme Q 10 .
18. The nutritional supplement of claim 9 , wherein the at least one vitamin is a cholesterol-reducing element.
19. The nutritional supplement of claim 9 , wherein the at least one herb or plant extract is a fat oxidation prevention element.
20. A nutritional supplement, comprising:
at least one vitamin;
at least one antioxidant;
at least one mineral;
at least one herb or plant extract selected from the group comprising Butcher's Broom, Ginkgo biloba, hawthorn, garlic, red rice yeast extract, resveratrol and ginger; and
a cardiovascular support component, consisting of:
an avian transfer factor preparation;
Vitamin C;
niacinamide;
an arginine-containing compound; and
a lysine-containing compound.
21. The composition of claim 20 , wherein:
the arginine-containing compound comprises magnesium arginate; and
the lysine-containing compound comprises magnesium lysinate.
22. The composition of claim 20 , comprising the preparation including transfer factor and the Vitamin C in substantially equal amounts.
23. The composition of claim 20 , wherein the avian transfer factor preparation is specific for at least one pathogen that directly causes a cardiovascular disorder or at least one antigen of at least one pathogen that directly causes the cardiovascular disorder.
24. A composition, comprising a preparation including transfer factor and Vitamin C, the preparation including transfer factor and the Vitamin C included in the composition in substantially equal amounts.
25. The composition of claim 24 , wherein the transfer factor is specific for at least one of herpes simplex virus-1, herpes simplex virus-2, cytomegalovirus, Chlamydia pneumoniae , and Helicobacter pylori.
26. The composition of claim 1 , wherein the transfer factor is an antigen-nonspecific transfer factor or a pathogen-nonspecific transfer factor.
27. The composition of claim 1 , wherein the transfer factor is a combination of nonspecific transfer factor and specific transfer factor.
28. The composition of claim 1 , wherein the transfer factor is an antigen-specific transfer factor or a pathogen-specific transfer factor.
29. The composition of claim 28 , wherein the transfer factor is specific for pathogenic agents that affect the circulatory system.
30. The composition of claim 29 , wherein the transfer factor is specific for pathogenic agents that cause cardiovascular complications.
31. The composition of claim 30 , wherein the transfer factor is specific for pathogenic agents that cause arterial walls to swell.
32. The composition of claim 1 , wherein the transfer factor is specific for at least one of cytomegalovirus, Chlamydia pneumoniae , and Helicobacter pylori.
33. The composition of claim 9 , wherein the pathogen-reducing component is a transfer factor-containing extract.
34. The composition of claim 33 , wherein transfer factor of the transfer factor-containing extract is specific for at least one of cytomegalovirus, Chlamydia pneumoniae , and Helicobacter pylori.
35. The composition of claim 20 , wherein transfer factor of the avian transfer factor preparation is specific for at least one of cytomegalovirus, Chlamydia pneumoniae , and Helicobacter pylori.